The novel injectable CMSCMA-sExo hydrogel composite scaffold may represent a promising therapeutic approach for treating SCI using urine-derived stem cell subpopulation exosomes.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: